INMED LLC.

In News

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance - TMX Newsfile

TMX Newsfile - Mar 27, 2026

[S-3] InMed Pharmaceuticals Inc. Shelf Registration Statement - Stock Titan

Stock Titan - Mar 20, 2026

InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline - TipRanks

TipRanks - Mar 06, 2026

InMed Announces Results of 2025 Annual General and Special Meeting - Investing News Network

Investing News Network - Dec 17, 2025

U.S. law threat pushes InMed to shut BayMedica unit, pivot to Alzheimer's drugs - Stock Titan

Stock Titan - Mar 06, 2026

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline - TMX Newsfile

TMX Newsfile - Mar 06, 2026

InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value - Investing News Network

Investing News Network - Nov 10, 2025

InMed (NASDAQ: INM) winds down BayMedica unit and pivots fully to drug development - Stock Titan

Stock Titan - Mar 06, 2026

InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update - Investing News Network

Investing News Network - Sep 23, 2025

InMed’s INM-901 Demonstrates Potential as a Multi-factorial Approach to Treating Alzheimer’s Disease - Fierce Biotech

Fierce Biotech - Jul 22, 2024

InMed Provides Update on BayMedica Commercial Business - Investing News Network

Investing News Network - Dec 12, 2025

INM SEC Filings - Inmed Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Stock Titan - Jun 29, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment